Guzi; Timothy J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Guzi; Timothy J..The latest application filed is for "substituted piperidines that increase p53 activity and the uses thereof".

Company Profile

2.64.68

Guzi; Timothy J. - Sudbury MA US
Guzi; Timothy J. - Chatham NJ
Guzi; Timothy J. - Ghatham NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anilinopiperazine derivatives and methods of use thereof Grant 9,206,142 - Shipps, Jr. , et al. December 8, 2	2015-12-08
Substituted piperidines as HDM2 inhibitors Grant 9,062,071 - Ma , et al. June 23, 2	2015-06-23
Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors Grant 8,993,535 - Popovici-Muller , et al. March 31, 2	2015-03-31
SUBSTITUTED PIPERIDINES THAT INCREASE p53 ACTIVITY AND THE USES THEREOF App 20140336222 - Bogen; Stephane L. ; et al.	2014-11-13
Substituted Piperidines As Hdm2 Inhibitors App 20140323482 - Ma; Yao ; et al.	2014-10-30
Substituted piperidines that increase p53 activity and the uses thereof Grant 8,859,776 - Bogen , et al. October 14, 2	2014-10-14
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors Grant 8,673,924 - Guzi , et al. March 18, 2	2014-03-18
Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors Grant 8,603,998 - Guzi , et al. December 10, 2	2013-12-10
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors Grant 8,586,576 - Guzi , et al. November 19, 2	2013-11-19
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors Grant 8,580,782 - Guzi , et al. November 12, 2	2013-11-12
Thiazole Derivatives as protein kinase inhibitors Grant 8,476,278 - Reddy , et al. July 2, 2	2013-07-02
Anilinopiperazine Derivatives And Methods Of Use Thereof App 20120328691 - Shipps, JR.; Gerald W. ; et al.	2012-12-27
2-aminothiazole-4-carboxylic amides as protein kinase inhibitors Grant 8,318,735 - Shipps, Jr. , et al. November 27, 2	2012-11-27
Heterocyclic amide compounds as protein kinase inhibitors Grant 8,293,747 - Reddy , et al. October 23, 2	2012-10-23
Substituted Piperidines That Increase P53 Activity And The Uses Thereof App 20120208844 - Bogen; Stephane L. ; et al.	2012-08-16
Modulators Of Cell Cycle Checkpoints And Their Use In Combination With Checkpoint Kinase Inhibitors App 20120184505 - Popovici-Muller; Janeta ; et al.	2012-07-19
Methods for inhibiting protein kinases Grant 8,211,854 - Guzi , et al. July 3, 2	2012-07-03
Synthesis Of Substituted-3-aminopyrazoles App 20120029204 - Alvarez; Carmen S. ; et al.	2012-02-02
Novel Modulators Of Cell Cycle Checkpoints And Their Use In Combination With Checkpoint Kinase Inhibitors App 20110183933 - Guzi; Timothy J. ; et al.	2011-07-28
Heterocyclic Urea and Thiourea Derivatives and Methods of Use Thereof App 20110129440 - Tadikonda; Praveen K. ; et al.	2011-06-02
Thiazole Derivatives as Protein Kinase Inhibitors App 20100331313 - Reddy; Panduranga Adulla P. ; et al.	2010-12-30
Heterocyclic Amide Compounds As Protein Kinase Inhibitors App 20100286135 - Reddy; Panduranga Adulla P. ; et al.	2010-11-11
N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,807,683 - Guzi , et al. October 5, 2	2010-10-05
Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors Grant 7,776,865 - Paruch , et al. August 17, 2	2010-08-17
2-aminothiazole-4-carboxylic Amides As Protein Kinase Inhibitors App 20100130465 - Shipps, JR.; Gerald W. ; et al.	2010-05-27
Methods For Inhibiting Protein Kinases App 20100125068 - Guzi; Timothy J. ; et al.	2010-05-20
Substituted pyrazolo[1,5-a] pyrimidines as protein kinase inhibitors Grant 7,645,762 - Paruch , et al. January 12, 2	2010-01-12
Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors Grant 7,642,266 - Guzi , et al. January 5, 2	2010-01-05
Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors Grant 7,605,155 - Guzi , et al. October 20, 2	2009-10-20
Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors Grant 7,601,724 - Guzi , et al. October 13, 2	2009-10-13
Imidazopyrazines as cyclin dependent kinase inhibitors Grant 7,576,085 - Guzi , et al. August 18, 2	2009-08-18
Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors Grant 7,563,798 - Guzi , et al. July 21, 2	2009-07-21
Imidazopyrazines as protein kinase inhibitors Grant 7,557,104 - Zhao , et al. July 7, 2	2009-07-07
Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,514,442 - Guzi , et al. April 7, 2	2009-04-07
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,511,049 - Guzi , et al. March 31, 2	2009-03-31
Imidazopyrazines as protein kinase inhibitors Grant 7,511,040 - Belanger , et al. March 31, 2	2009-03-31
17.beta.-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases Grant 7,485,645 - Guzi , et al. February 3, 2	2009-02-03
17.beta.-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases Grant 7,476,681 - Paruch , et al. January 13, 2	2009-01-13
N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,470,695 - Guzi , et al. December 30, 2	2008-12-30
Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,468,372 - Guzi , et al. December 23, 2	2008-12-23
Imidazopyridines as cyclin dependent kinase inhibitors Grant 7,452,902 - Dwyer , et al. November 18, 2	2008-11-18
Pyrazolopyrimidines as protein kinase inhibitors Grant 7,449,488 - Paruch , et al. November 11, 2	2008-11-11
Imidazopyrazines as cyclin dependent kinase inhibitors Grant 7,432,265 - Paruch , et al. October 7, 2	2008-10-07
Imidazopyrazines As Protein Kinase Inhibitors App 20080139571 - Belanger; David B. ; et al.	2008-06-12
Pyrazolotriazines as kinase inhibitors Grant 7,354,921 - Guzi , et al. April 8, 2	2008-04-08
Farnesyl protein transferase inhibitors as antitumor agents Grant 7,342,016 - Zhu , et al. March 11, 2	2008-03-11
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20080050384 - Guzi; Timothy J. ; et al.	2008-02-28
Imidazopyrazines As Protein Kinase Inhibitors App 20080027063 - Zhao; Lianyun ; et al.	2008-01-31
17beta-hydroxysteroid Dehydrogenase Type 3 Inhibitors For The Treatment Of Androgen Dependent Diseases App 20080004248 - Guzi; Timothy J. ; et al.	2008-01-03
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,309,705 - Guzi , et al. December 18, 2	2007-12-18
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20070281951 - Guzi; Timothy J. ; et al.	2007-12-06
Novel Pyrazolopyrimidines As Cyclin Dependent Kinase Inhibitors App 20070275983 - Guzi; Timothy J. ; et al.	2007-11-29
PYRAZOLO[1,5-a]PYRIMIDINES App 20070275963 - Guzi; Timothy J. ; et al.	2007-11-29
Pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20070225270 - Guzi; Timothy J. ; et al.	2007-09-27
17.beta.-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases Grant 7,271,175 - Guzi , et al. September 18, 2	2007-09-18
Novel Imidazopyrazines As Cyclin Dependent Kinase Inhibitors App 20070155751 - PARUCH; KAMIL ; et al.	2007-07-05
Imidazopyrazines as protein kinase inhibitors App 20070117804 - Zhao; Lianyun ; et al.	2007-05-24
Methods for inhibiting protein kinases App 20070105864 - Guzi; Timothy J. ; et al.	2007-05-10
Trisubstituted 7-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,205,308 - Guzi , et al. April 17, 2	2007-04-17
Pyrazolopyrimidines as protein kinase inhibitors App 20070082901 - Guzi; Timothy J. ; et al.	2007-04-12
Pyrazolopyrimidines as protein kinase inhibitors App 20070082902 - Paruch; Kamil ; et al.	2007-04-12
Methods for inhibiting protein kinases App 20070082900 - Guzi; Timothy J. ; et al.	2007-04-12
Pyrazolopyrimidines as protein kinase inhibitors App 20070083044 - Paruch; Kamil ; et al.	2007-04-12
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20070072880 - Guzi; Timothy J. ; et al.	2007-03-29
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20070072881 - Guzi; Timothy J. ; et al.	2007-03-29
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20070072882 - Guzi; Timothy J. ; et al.	2007-03-29
N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,196,092 - Guzi , et al. March 27, 2	2007-03-27
Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,196,078 - Guzi , et al. March 27, 2	2007-03-27
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20070054925 - Guzi; Timothy J. ; et al.	2007-03-08
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20070054906 - Guzi; Timothy J. ; et al.	2007-03-08
Imidazopyrazines as cyclin dependent kinase inhibitors Grant 7,186,740 - Paruch , et al. March 6, 2	2007-03-06
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20070037824 - Guzi; Timothy J. ; et al.	2007-02-15
Pyrazolotriazines as kinase inhibitors App 20070032495 - Guzi; Timothy J. ; et al.	2007-02-08
Pyrazolotriazines as kinase inhibitors Grant 7,166,602 - Guzi , et al. January 23, 2	2007-01-23
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,161,003 - Guzi , et al. January 9, 2	2007-01-09
Pyrazolopyridines as cyclin dependent kinase inhibitors Grant 7,151,104 - Dwyer , et al. December 19, 2	2006-12-19
Compounds for inhibiting KSP Kinesin activity App 20060281778 - Tagat; Jayaram R. ; et al.	2006-12-14
17 .beta.-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases Grant 7,138,396 - Guzi , et al. November 21, 2	2006-11-21
Compounds for inhibiting KSP kinesin activity App 20060247320 - Tagat; Jayaram R. ; et al.	2006-11-02
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20060235025 - Guzi; Timothy J. ; et al.	2006-10-19
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,119,200 - Guzi , et al. October 10, 2	2006-10-10
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20060178371 - Guzi; Timothy J. ; et al.	2006-08-10
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20060173016 - Guzi; Timothy J. ; et al.	2006-08-03
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20060173017 - Guzi; Timothy J. ; et al.	2006-08-03
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,084,271 - Guzi , et al. August 1, 2	2006-08-01
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,078,525 - Guzi , et al. July 18, 2	2006-07-18
17.beta.-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases Grant 7,074,795 - Paruch , et al. July 11, 2	2006-07-11
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,074,924 - Guzi , et al. July 11, 2	2006-07-11
17Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases App 20060148816 - Paruch; Kamil ; et al.	2006-07-06
17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases App 20060142338 - Guzi; Timothy J. ; et al.	2006-06-29
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,067,661 - Guzi , et al. June 27, 2	2006-06-27
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20060128725 - Guzi; Timothy J. ; et al.	2006-06-15
Pyrazolotriazines as kinase inhibitors App 20060122389 - Guzi; Timothy J. ; et al.	2006-06-08
17 .beta.-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases Grant 7,053,091 - Guzi , et al. May 30, 2	2006-05-30
Novel imidazopyrazines as cyclin dependent kinase inhibitors App 20060106023 - Guzi; Timothy J. ; et al.	2006-05-18
Pyrazolopyrimidines as protein kinase inhibitors App 20060094706 - Paruch; Kamil ; et al.	2006-05-04
Pyrazolotriazines as kinase inhibitors Grant 7,038,045 - Guzi , et al. May 2, 2	2006-05-02
17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases App 20060069103 - Guzi; Timothy J. ; et al.	2006-03-30
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20060040958 - Guzi; Timothy J. ; et al.	2006-02-23
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20060041131 - Guzi; Timothy J. ; et al.	2006-02-23
Novel imidazopyridines as cyclin dependent kinase inhibitors App 20060030555 - Dwyer; Michael P. ; et al.	2006-02-09
Imidazopyridines as cyclin dependent kinase inhibitors Grant 6,992,080 - Dwyer , et al. January 31, 2	2006-01-31
17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases App 20060014755 - Guzi; Timothy J. ; et al.	2006-01-19
17-.beta. hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases Grant 6,969,718 - Guzi , et al. November 29, 2	2005-11-29
Pyrazolotriazines as kinase inhibitors App 20050187219 - Guzi, Timothy J. ; et al.	2005-08-25
Imidazopyrazines as cyclin dependent kinase inhibitors Grant 6,919,341 - Paruch , et al. July 19, 2	2005-07-19
Novel imidazopyrazines as cyclin dependent kinase inhibitors App 20050130980 - Paruch, Kamil ; et al.	2005-06-16
17.beta.-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases Grant 6,903,102 - Guzi , et al. June 7, 2	2005-06-07
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20040209878 - Guzi, Timothy J. ; et al.	2004-10-21
17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases App 20040138226 - Guzi, Timothy J. ; et al.	2004-07-15
17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases App 20040132736 - Guzi, Timothy J. ; et al.	2004-07-08
17Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases App 20040127503 - Paruch, Kamil ; et al.	2004-07-01
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20040116442 - Guzi, Timothy J. ; et al.	2004-06-17
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20040106624 - Guzi, Timothy J. ; et al.	2004-06-03
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20040102452 - Guzi, Timothy J. ; et al.	2004-05-27
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20040102451 - Guzi, Timothy J. ; et al.	2004-05-27
Novel pyrazolopyridines as cyclin dependent kinase inhibitors App 20040097516 - Dwyer, Michael P. ; et al.	2004-05-20
Novel imidazopyridines as cyclin dependent kinase inhibitors App 20040097517 - Dwyer, Michael P. ; et al.	2004-05-20
Treatment of malaria with farnesyl protein transferase inhibitors App 20040087592 - Windsor, William T. ; et al.	2004-05-06
Novel imidazopyrazines as cyclin dependent kinase inhibitors App 20040072835 - Paruch, Kamil ; et al.	2004-04-15
Novel imidazopyrazines as cyclin dependent kinase inhibitors App 20040063715 - Paruch, Kamil ; et al.	2004-04-01
17-Beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases App 20030232837 - Guzi, Timothy J. ; et al.	2003-12-18
Treatment of malaria with farnesyl protein transferase inhibitors App 20030092705 - Windsor, William T. ; et al.	2003-05-15
Farnesyl protein transferase inhibitors Grant 6,399,615 - Guzi , et al. June 4, 2	2002-06-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.